Endogenous Biocatalytic Reaction-Based Nanoplatform for Multifunctional Tumor Theranostics

Shu Sheng,Lin Lin,Feng Liu,Ying Zhang,Caina Xu,Kai Hao,Dianwei Wang,Huayu Tian,Xuesi Chen

DOI: https://doi.org/10.1021/acs.chemmater.2c01648

IF: 10.508

2022-09-23

Chemistry of Materials

Abstract:Nanotheranostic agents based on endogenous biocatalytic reactions triggered by the tumor microenvironment (TME) have better specificity and biosafety. Herein, we developed a strategy for tumor-specific imaging-guided enhanced combination tumor therapy by introducing endogenous biocatalytic reaction. Tyrosinase and tyrosine could germinate the endogenous biocatalytic reaction in the acidic TME to produce endogenous melanin with the capabilities of photoacoustic imaging and photothermal therapy. The nanocarrier MIL-100 possessed dual roles during the endogenous biocatalytic reaction, namely, coordinating with the catechol moieties and promoting biocatalysis. Besides, MIL-100 could convert overexpressed H2O2 in the tumor site to O2, which was also conducive to enzymatic catalysis. Furthermore, MIL-100 mediated the production of hydroxyl radicals through the Fenton reaction while depleting GSH to achieve enhanced chemodynamic therapy, ultimately accomplishing prominent therapeutic outcomes via combination therapy. More importantly, the reducibility of GSH could induce the degradation of MIL-100. Overall, this work paved a new approach for constructing a biosafe multifunctional theranostic agent.

materials science, multidisciplinary,chemistry, physical